Earth Science Tech, Inc. Files 10-K/A Amendment

TL;DR

<b>Earth Science Tech, Inc. (ETST) has filed an amended 10-K for the fiscal year ending March 31, 2023.</b>

AI Summary

Earth Science Tech, Inc. (ETST) filed a Amended Annual Report (10-K/A) with the SEC on February 27, 2024. Filing is an amendment to the 10-K for the fiscal year ended March 31, 2023. Company is Earth Science Tech, Inc. (ETST), incorporated in Nevada. Primary business address is in Miami, Florida. Former company name was Ultimate Novelty Sports Inc., changed on December 30, 2011. SIC code is Pharmaceutical Preparations [2834].

Why It Matters

For investors and stakeholders tracking Earth Science Tech, Inc., this filing contains several important signals. This amended filing indicates potential updates or corrections to the company's annual financial reporting. The amendment suggests that investors and stakeholders should review the latest version for the most accurate financial and operational information.

Risk Assessment

Risk Level: low — Earth Science Tech, Inc. shows low risk based on this filing. The filing is an amendment to a 10-K, which typically indicates corrections or updates rather than new material events, suggesting a lower immediate risk impact.

Analyst Insight

Review the specific changes made in this 10-K/A filing to understand the nature of the amendments and their potential impact on the company's reported financials or operations.

Revenue Breakdown

Key Numbers

• 2023-03-31 — Fiscal Year End (Reported period)
• 2024-02-27 — Filing Date (Date of submission)
• 000-55000 — SEC File Number (Associated SEC filing number)
• 2834 — SIC Code (Standard Industrial Classification for Pharmaceutical Preparations)

Key Players & Entities

• Earth Science Tech, Inc. (company) — Filer name
• ETST (company) — Ticker symbol
• Ultimate Novelty Sports Inc. (company) — Former company name
• 2023-03-31 (date) — Fiscal year end
• 2024-02-27 (date) — Filing date
• 2834 (industry) — Standard Industrial Classification
• NV (state) — State of incorporation
• MIAMI (location) — Business address city

FAQ

Key Dates

• 2023-03-31: Fiscal Year End — End of the reporting period for the 10-K filing.
• 2024-02-27: Filing Date — Date the 10-K/A amendment was filed with the SEC.
• 2011-12-30: Company Name Change — Date Earth Science Tech, Inc. changed from Ultimate Novelty Sports Inc.

Key Financial Figures

• $0.001 — ange on which registered Common Stock $0.001 par value ETST Over the Counter Bul
• $13,861 — of Income was to reduce the Net loss by $13,861 for the year ended March 31, 2023. (I

Filing Documents

• form10-ka.htm (10-K/A) — 1037KB
• ex3-2.htm (EX-3.2) — 4KB
• ex31-1.htm (EX-31.1) — 13KB
• ex31-2.htm (EX-31.2) — 13KB
• ex32-1.htm (EX-32.1) — 8KB
• ex32-2.htm (EX-32.2) — 8KB
• ex99-1.htm (EX-99.1) — 3KB
• form10-ka_001.jpg (GRAPHIC) — 2KB
• ex3-2_001.jpg (GRAPHIC) — 442KB
• ex3-2_002.jpg (GRAPHIC) — 413KB
• ex3-2_003.jpg (GRAPHIC) — 533KB
• ex3-2_004.jpg (GRAPHIC) — 586KB
• ex3-2_005.jpg (GRAPHIC) — 488KB
• ex3-2_006.jpg (GRAPHIC) — 576KB
• ex99-1_001.jpg (GRAPHIC) — 890KB
• ex99-1_002.jpg (GRAPHIC) — 601KB
• ex99-1_003.jpg (GRAPHIC) — 433KB
• ex99-1_004.jpg (GRAPHIC) — 130KB
• 0001493152-24-007930.txt (&nbsp;) — 11822KB
• etst-20230331.xsd (EX-101.SCH) — 37KB
• etst-20230331_cal.xml (EX-101.CAL) — 51KB
• etst-20230331_def.xml (EX-101.DEF) — 130KB
• etst-20230331_lab.xml (EX-101.LAB) — 281KB
• etst-20230331_pre.xml (EX-101.PRE) — 229KB
• form10-ka_htm.xml (XML) — 665KB

financial statements in this Form 10-K/A

financial statements in this Form 10-K/A. TABLE OF CONTENTS PAGE PART I Item 1. Business. 4 Item 1A. Risk Factors. 5 Item 1B. Unresolved Staff Comments. 10 Item 2. Properties. 10 Item 3. Legal Proceedings. 10 Item 4. Mine Safety Disclosure. 10 PART II Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. 10 Item 6.

Selected Financial Data

Selected Financial Data 13 Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations. 13 Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk. 18 Item 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data. 18 Item 9A.

Controls and Procedures

Controls and Procedures. 20 Item 9B. Other Information. 20 PART III Item 10. Directors, Executive Officers and Corporate Governance. 21 Item 11.

Executive Compensation

Executive Compensation. 22 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. 24 Item 13. Certain Relationships and Related Transactions, and Director Independence. 26 Item 14. Principal Accounting Fees and Services. 26 PART IV Item 15. Exhibits, Financial Statement Schedules. 27 Item 16. FORM 10-K Summary 27

SIGNATURES

SIGNATURES 28 2 WHERE YOU CAN FIND MORE INFORMATION We file annual, quarterly, and current reports, proxy statements and other information required by the Securities Exchange Act of 1934, as amended (the "Exchange Act"), with the Securities and Exchange Commission (the "SEC"). You may read and copy any document we file with the SEC at the SEC's public reference room located at 100 F Street, N.E., Washington, D.C. 20549, U.S.A. Please call the SEC at 1-800-SEC-0330 for further information on the public reference room. Our SEC filings are also available to the public from the SEC's internet site at http://www.sec.gov . On our Internet website, http://www.earthsciencetech.com, we post the following recent filings as soon as reasonably practicable after they are electronically filed with or furnished to the SEC: our annual reports on Form 10-K, our quarterly reports on Form 10-Q, our current reports on Form 8-K, and any amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act. When we use the terms "ETST", "Company", "we", "our" and "us" we mean Earth Science Tech, Inc., a Florida corporation, and its consolidated subsidiaries, taken as a whole, as well as any predecessor entities, unless the context indicates otherwise. FORWARD LOOKING STATEMENTS This Annual Report on Form 10-K, the other reports, statements, and information that the Company has previously filed with or furnished to, or that we may subsequently file with or furnish to, the SEC, and public announcements that we have previously made or may subsequently make include, may include, or may incorporate by reference certain statements that may be deemed to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and that are intended to enjoy the protection of the safe harbor for forward-looking statements provided by that Act. To the extent that any statements made in this report contain

BUSINESS

BUSINESS BACKGROUND AND OVERVIEW Earth Science Tech, Inc. ("ETST" or the "Company") was incorporated under the laws of the State of Nevada on April 23, 2010, and subsequently changed its domicile to the State of Florida on June 27, 2022. As of November 8, 2022, the Company is a holding entity set to acquire companies with its current focus in the health and wellness industry. The Company is presently in compounding pharmaceuticals and telemedicine through its wholly owned subsidiaries RxCompoundStore.com, LLC. ("RxCompound"), Peaks Curative, LLC. ("Peaks"), and Earth Science Foundation, Inc. ("ESF"). RxCompound is a complete compounding pharmacy. RxCompound is currently licensed to fulfill prescriptions in the states of Florida, New York, New Jersey, Delaware, Pennsylvania, Rhode Island, Nevada, Colorado, and Arizona. RxCompound is in the application process to obtain licenses in the remaining states in which it is not yet licensed to fulfill prescriptions. Peaks is a telemedicine referral site focused on men's health. Peaks' orders are exclusively fulfilled by RxCompound. Patients who order Peaks via monthly subscription receive their refills automatically. Currently, Peaks is focused on Men's health, and, more specifically, ED. The company intends to expand offerings to include over the counter ("OTC") (non-prescription) products such as supplements and topicals. The OTC products will be custom manufactured or fulfilled through partnered companies under the Peaks brand and offered worldwide. ESF is a favored entity of the Company, effectively being a non-profit organization that was incorporated on February 11, 2019, and is structured to accept grants and donations to help those in need of assistance in paying for prescriptions. Current Operations CORPORATE STRATEGY The Company operates as a holding entity with a presence in the telehealth and compounding pharmaceutical sectors. Its primary objective is to deliver contemporary and personalized health

View Full Filing

View this 10-K/A filing on SEC EDGAR